During the past decade, Eric M White OD, Inc. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 8 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Eric M White OD, Inc." are "Myopia" (3 trials), "Ametropia" (2 trials), "Dry Eye Syndromes" (2 trials), "Dry Eye Disease (DED)" (1 trials) and "Refractive Error" (1 trials). Many other conditions were trialed in "Eric M White OD, Inc." in a lesser frequency.

Most popular intervention types in "Eric M White OD, Inc." are "Device" (6 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "enfilcon A" (2 trials), "011516X (New Artificial Tear Formulation)" (1 trials), "Carboxymethylcellulose Based Eye Drop" (1 trials), "Carboxymethylcellulose Sodium 0.5%" (1 trials) and "Pearl" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eric M White OD, Inc." are 9 trials for "All" genders.

Currently, there are NaN active trials in "Eric M White OD, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Eric M White OD, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Eric M White OD, Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".